Pulmonx (LUNG) Cost of Revenue (2019 - 2025)
Pulmonx (LUNG) posted quarterly Cost of Revenue of $5.4 million for Q3 2025, up 1.66% year-over-year from $5.4 million in Q3 2024, and down 18.11% quarter-over-quarter from $6.7 million in Q2 2025.
Pulmonx (LUNG) Cost of Revenue (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Cost of Revenue for 7 consecutive years, with $5.4 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cost of Revenue rose 1.66% year-over-year to $5.4 million; the TTM figure through Sep 2025 stood at $24.5 million (up 19.45% YoY), while the FY2024 annual figure was $21.8 million, up 21.56% from the prior year.
- Cost of Revenue eased to $5.4 million in Q3 2025 per LUNG's latest filing, from $6.7 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $6.7 million in Q2 2025 and bottomed at $500000.0 in Q4 2022.
- Historically, Cost of Revenue has averaged $4.3 million across 5 years, with a median of $4.5 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue plunged 85.54% — and 2023, when it jumped 875.6%.
- Pulmonx's Cost of Revenue stood at $3.5 million in 2021, then sank by 85.54% to $500000.0 in 2022, then surged by 875.6% to $4.9 million in 2023, then gained by 26.59% to $6.2 million in 2024, then dropped by 11.74% to $5.4 million in 2025.
- Business Quant data shows LUNG's Cost of Revenue at $5.4 million in Q3 2025, $6.7 million in Q2 2025, and $6.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Pulmonx | 97.63 Mn | 27.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.45 Mn |
| Sep 30, 2025 | 5.45 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 6.66 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 5.48 Mn |
| Mar 31, 2024 | 4.78 Mn |
| Mar 31, 2024 | 4.78 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Jun 30, 2023 | 4.46 Mn |